Effectiveness of Using Human Platelet Lysate (hPL) to Treat Supraspinatus Tendinopathy - Clinical Trial

Hospital São Paulo0 个研究点目标入组 30 人开始时间: 2020年1月28日最近更新: 2020年2月24日

试验速览

暂无简介。

•1. Over 40 years old
•2. Pain in the anterolateral shoulder region, without irradiation to the forearm region
•3. Pain for more than 3 months of symptoms (measured by Visual Analog Scale)
•4. Physical examination (positive Neer test, associated with the Hawkins Kennedy Test and the positive Jobe test) plus magnetic resonance imaging compatible with supraspinatus tendinopathy or partial lesion less than 50%, evaluated by 3 independent evaluators (two orthopedists and a radiologist)
•5. Submit and accept the term of clarification and free consent
•6. Have not undergone surgery or local injection in the shoulder
•7. Agree and sign the free and informed consent form

•1. Bilateral supraspinatus tendon lesions
•2. Presence of fractures, surgeries, infiltrations or previous injuries to the affected shoulder
•3. Any condition that is a contraindication to interventions
•4. Restriction of passive shoulder range of motion on physical examination
•5. Signs of other associated diseases on MRI, except acromioclavicular degeneration
•6. Platelets of less than 50,000
•7. Contraindication to use any component of the proposed treatments

发起方